Gilead Offers Up $4.3bn For CymaBay And Phase III PBC Candidate

 
• By Joseph Haas
  
Gilead
Gilead adds in liver with CymaBay acquisition • Source: Shutterstock: Tada Images
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business